Cardiovascular and Metabolic Complications – Diagnosis and Management in Obese Children

Review Article

Abstract

The world at present is facing a burden of rising prevalence of obesity in children and adolescents. The developing countries are particularly facing the dual burden on under-nutrition and obesity. This is associated with appearance and clustering of cardiometabolic abnormalities at an early age with development of chronic complications early and possible decrease in life span of these children and adolescents. In adults this clustering has been termed as ‘metabolic syndrome’ with definitions that can be used universally. However, in children and adolescents there is no consensus on a uniform definition of metabolic syndrome that can be applicable across the age groups and various ethnicities. Further, as childhood is a period of growth and development, changes in body composition and insulin sensitivity that occur with puberty may influence the thresholds of components used to define metabolic syndrome. Children of South Asian ethnicity appear to be more predisposed to develop abnormalities of metabolic syndrome, possible due to their adverse body fat patterning and genetic influences. The definition of pediatric metabolic syndrome proposed by International Diabetes Federation is useful across different ethnicities. Presence of at least one component of metabolic syndrome should lead to detailed screening for other components and complications. A multimodality approach including therapeutic lifestyle changes targeted at the individual, family and community is essential for management. Pharmacotherapy for individual components may be required if initial management strategies fail to achieve the goals.

Keywords

Childhood obesity Asian Indians Insulin resistance Metabolic syndrome 

Notes

Acknowledgements

The author acknowledges Prof. Vandana Jain for sharing her unpublished data for the manuscript.

Compliance with Ethical Standards

Conflict of Interest

None.

Source of Funding

None.

References

  1. 1.
    Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA. 2012;307:483–90.CrossRefPubMedGoogle Scholar
  2. 2.
    Singhal N, Misra A, Shah P, Rastogi K, Vikram NK. Secular trends in obesity, regional adiposity and metabolic parameters among Asian Indian adolescents in north India: a comparative data analysis of two selective samples 5 years apart (2003, 2008). Ann Nutr Metab. 2010;56:176–81.CrossRefPubMedGoogle Scholar
  3. 3.
    Misra A, Shah P, Goel K, et al. The high burden of obesity and abdominal obesity in urban Indian schoolchildren: a multicentric study of 38,296 children. Ann Nutr Metab. 2011;58:203–11.CrossRefPubMedGoogle Scholar
  4. 4.
    Ajala O, Mold F, Boughton C, Cooke D, Whyte M. Childhood predictors of cardiovascular disease in adulthood. A systematic review and meta-analysis. Obes Rev. 2017.  https://doi.org/10.1111/obr.12561.
  5. 5.
    Taittonen L, Uhari M, Nuutinen M, Turtinen J, Pokka T, Akerblom HK. Insulin and blood pressure among healthy children. Cardiovascular risk in young Finns. Am J Hypertens. 1996;9:194–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Goel R, Misra A, Agarwal SK, Vikram N. Correlates of hypertension among urban Asian Indian adolescents. Arch Dis Child. 2010;95:992–7.CrossRefPubMedGoogle Scholar
  7. 7.
    Schinner S, Scherbaum WA, Bornstein SR, Barthel A. Molecular mechanisms of insulin resistance. Diabet Med. 2005;22:674–82.CrossRefPubMedGoogle Scholar
  8. 8.
    Sinaiko AR, Jacobs DR Jr, Steinberger J, et al. Insulin resistance syndrome in childhood: associations of the euglycemic insulin clamp and fasting insulin with fatness and other risk factors. J Pediatr. 2001;139:700–7.CrossRefPubMedGoogle Scholar
  9. 9.
    Vikram NK, Misra A, Pandey RM, Luthra K, Wasir JS, Dhingra V. Heterogeneous phenotypes of insulin resistance and its implications for defining metabolic syndrome in Asian Indian adolescents. Atherosclerosis. 2006;186:193–9.CrossRefPubMedGoogle Scholar
  10. 10.
    Bavdekar A, Yajnik CS, Fall CH, et al. Insulin resistance syndrome in 8-year-old Indian children: small at birth, big at 8 years, or both? Diabetes. 1999;48:2422–9.CrossRefPubMedGoogle Scholar
  11. 11.
    Raitakari OT, Porkka KV, Ronnemaa T, et al. The role of insulin in clustering of serum lipids and blood pressure in children and adolescents. The Cardiovascular Risk in Young Finns Study. Diabetologia. 1995;38:1042–50.CrossRefPubMedGoogle Scholar
  12. 12.
    van der Aa MP, Knibbe CA, Boer A, van der Vorst MM. Definition of insulin resistance affects prevalence rate in pediatric patients: a systematic review and call for consensus. J Pediatr Endocrinol Metab. 2017;30:123–31.PubMedGoogle Scholar
  13. 13.
    Singh Y, Garg MK, Tandon N, Marwaha RK. A study of insulin resistance by HOMA-IR and its cut-off value to identify metabolic syndrome in urban Indian adolescents. J Clin Res Pediatr Endocrinol. 2013;5:245–51.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Esmaillzadeh A, Mirmiran P, Azizi F. Clustering of metabolic abnormalities in adolescents with the hypertriglyceridemic waist phenotype. Am J Clin Nutr. 2006;83:36–46; quiz 183-4.Google Scholar
  15. 15.
    Kang HS, Gutin B, Barbeau P, Litaker MS, Allison J, Le NA. Low-density lipoprotein particle size, central obesity, cardiovascular fitness, and insulin resistance syndrome markers in obese youths. Int J Obes Relat Metab Disord. 2002;26:1030–5.CrossRefPubMedGoogle Scholar
  16. 16.
    Selvakumar PKC, Kabbany MN, Nobili V, Alkhouri N. Nonalcoholic fatty liver disease in children: hepatic and extrahepatic complications. Pediatr Clin N Am. 2017;64:659–75.CrossRefGoogle Scholar
  17. 17.
    Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595–607.CrossRefPubMedGoogle Scholar
  18. 18.
    Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–53.CrossRefPubMedGoogle Scholar
  19. 19.
    Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735–52.CrossRefPubMedGoogle Scholar
  20. 20.
    Alberti KG, Zimmet P, Shaw J. Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23:469–80.CrossRefPubMedGoogle Scholar
  21. 21.
    Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–5.CrossRefPubMedGoogle Scholar
  22. 22.
    Raitakari OT, Porkka KV, Viikari JS, Ronnemaa T, Akerblom HK. Clustering of risk factors for coronary heart disease in children and adolescents. The Cardiovascular Risk in Young Finns Study. Acta Paediatr. 1994;83:935–40.CrossRefPubMedGoogle Scholar
  23. 23.
    Chu NF, Rimm EB, Wang DJ, Liou HS, Shieh SM. Clustering of cardiovascular disease risk factors among obese schoolchildren: the Taipei Children Heart Study. Am J Clin Nutr. 1998;67:1141–6.PubMedGoogle Scholar
  24. 24.
    Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med. 2003;157:821–7.CrossRefPubMedGoogle Scholar
  25. 25.
    Duncan GE, Li SM, Zhou XH. Prevalence and trends of a metabolic syndrome phenotype among U.S. Adolescents, 1999-2000. Diabetes Care. 2004;27:2438–43.CrossRefPubMedGoogle Scholar
  26. 26.
    de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation. 2004;110:2494–7.CrossRefPubMedGoogle Scholar
  27. 27.
    Rodriguez-Moran M, Salazar-Vazquez B, Violante R, Guerrero-Romero F. Metabolic syndrome among children and adolescents aged 10-18 years. Diabetes Care. 2004;27:2516–7.CrossRefPubMedGoogle Scholar
  28. 28.
    Goodman E, Daniels SR, Morrison JA, Huang B, Dolan LM. Contrasting prevalence of and demographic disparities in the World Health Organization and National Cholesterol Education Program Adult Treatment Panel III definitions of metabolic syndrome among adolescents. J Pediatr. 2004;145:445–51.CrossRefPubMedGoogle Scholar
  29. 29.
    Lambert M, Paradis G, O'Loughlin J, Delvin EE, Hanley JA, Levy E. Insulin resistance syndrome in a representative sample of children and adolescents from Quebec, Canada. Int J Obes Relat Metab Disord. 2004;28:833–41.CrossRefPubMedGoogle Scholar
  30. 30.
    Jolliffe CJ, Janssen I. Development of age-specific adolescent metabolic syndrome criteria that are linked to the Adult Treatment Panel III and International Diabetes Federation criteria. J Am Coll Cardiol. 2007;49:891–8.CrossRefPubMedGoogle Scholar
  31. 31.
    Ahrens W, Moreno LA, Marild S, et al. Metabolic syndrome in young children: definitions and results of the IDEFICS study. Int J Obes. 2014;38:S4–14.CrossRefGoogle Scholar
  32. 32.
    Magnussen CG, Cheriyan S, Sabin MA, et al. Continuous and dichotomous metabolic syndrome definitions in youth predict adult type 2 diabetes and carotid artery intima media thickness: the cardiovascular risk in young finns study. J Pediatr. 2016;171:97–103.e1–3.CrossRefPubMedGoogle Scholar
  33. 33.
    Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350:2362–74.CrossRefPubMedGoogle Scholar
  34. 34.
    Singh R, Bhansali A, Sialy R, Aggarwal A. Prevalence of metabolic syndrome in adolescents from a north Indian population. Diabet Med. 2007;24:195–9.CrossRefPubMedGoogle Scholar
  35. 35.
    Kapil U, Kaur S. Prevalence of pediatrics metabolic syndrome (PMS) amongst children in the age group of 6-18 years belonging to high income group residing in national capital territory (NCT) of Delhi. Indian J Pediatr. 2010;77:1041.CrossRefPubMedGoogle Scholar
  36. 36.
    Tandon N, Garg MK, Singh Y, Marwaha RK. Prevalence of metabolic syndrome among urban Indian adolescents and its relation with insulin resistance (HOMA-IR). J Pediatr Endocrinol Metab. 2013;26:1123–30.CrossRefPubMedGoogle Scholar
  37. 37.
    Andrabi SM, Bhat MH, Andrabi SR, et al. Prevalence of metabolic syndrome in 8-18-year-old school-going children of Srinagar city of Kashmir India. Indian J Endocrinol Metab. 2013;17:95–100.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Reinehr T, Wolters B, Knop C, Lass N, Holl RW. Strong effect of pubertal status on metabolic health in obese children: a longitudinal study. J Clin Endocrinol Metab. 2015;100:301–8.CrossRefPubMedGoogle Scholar
  39. 39.
    Reinehr T. Metabolic syndrome in children and adolescents: a critical approach considering the interaction between pubertal stage and insulin resistance. Curr Diab Rep. 2016;16:8.CrossRefPubMedGoogle Scholar
  40. 40.
    Zimmet P, Alberti KG, Kaufman F, et al. The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes. 2007;8:299–306.CrossRefPubMedGoogle Scholar
  41. 41.
    Katzmarzyk PT, Perusse L, Malina RM, Bergeron J, Despres JP, Bouchard C. Stability of indicators of the metabolic syndrome from childhood and adolescence to young adulthood: the Quebec Family Study. J Clin Epidemiol. 2001;54:190–5.CrossRefPubMedGoogle Scholar
  42. 42.
    Morrison JA, Friedman LA, Wang P, Glueck CJ. Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later. J Pediatr. 2008;152:201–6.CrossRefPubMedGoogle Scholar
  43. 43.
    Gustafson JK, Yanoff LB, Easter BD, et al. The stability of metabolic syndrome in children and adolescents. J Clin Endocrinol Metab. 2009;94:4828–34.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128:S213–56.Google Scholar
  45. 45.
    Asghari G, Yuzbashian E, Mirmiran P, Hooshmand F, Najafi R, Azizi F. Dietary approaches to stop hypertension (DASH) dietary pattern is associated with reduced incidence of metabolic syndrome in children and adolescents. J Pediatr. 2016;174:178–84.e1.CrossRefPubMedGoogle Scholar
  46. 46.
    Misra A, Sharma R, Gulati S, et al. Consensus dietary guidelines for healthy living and prevention of obesity, the metabolic syndrome, diabetes, and related disorders in Asian Indians. Diabetes Technol Ther. 2011;13:683–94.CrossRefPubMedGoogle Scholar
  47. 47.
    Misra A, Nigam P, Hills AP, et al. Consensus physical activity guidelines for Asian Indians. Diabetes Technol Ther. 2012;14:83–98.CrossRefPubMedGoogle Scholar
  48. 48.
    Falkner B, Daniels SR. Summary of the fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Hypertension. 2004;44:387–8.CrossRefPubMedGoogle Scholar
  49. 49.
    Styne DM, Arslanian SA, Connor EL, et al. Pediatric obesity-assessment, treatment, and prevention: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2017;102:709–57.CrossRefPubMedGoogle Scholar
  50. 50.
    Rajjo T, Mohammed K, Alsawas M, et al. Treatment of pediatric obesity: an umbrella systematic review. J Clin Endocrinol Metab. 2017;102:763–75.PubMedGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2017

Authors and Affiliations

  1. 1.Department of Medicine, Metabolic Research GroupAll India Institute of Medical SciencesNew DelhiIndia

Personalised recommendations